Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 13
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
13| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10398681 | ATTRUBYacoramidis hydrochloride | product | May 2031 |
| 10842777 | ATTRUBYacoramidis hydrochloride | use | May 2031 |
| 8877795 | ATTRUBYacoramidis hydrochloride | product | May 2031 |
| 9169214 | ATTRUBYacoramidis hydrochloride | product | May 2031 |
| 9642838 | ATTRUBYacoramidis hydrochloride | substance, product | May 2031 |
| 9913826 | ATTRUBYacoramidis hydrochloride | use | May 2031 |
| 10513497 | ATTRUBYacoramidis hydrochloride | substance | Feb 2038 |
| 11919865 | ATTRUBYacoramidis hydrochloride | use | Feb 2038 |
| 11058668 | ATTRUBYacoramidis hydrochloride | use | Mar 2039 |
| 12070449 | ATTRUBYacoramidis hydrochloride | use | Mar 2039 |
| 11260047 | ATTRUBYacoramidis hydrochloride | product | Aug 2039 |
| 12005043 | ATTRUBYacoramidis hydrochloride | product | Aug 2039 |
| 12539290 | ATTRUBYacoramidis hydrochloride | product | Aug 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| ATTRUBYACORAMIDIS HYDROCHLORIDE | ODE-506 Orphan drug | Nov 2031 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Attruby | acoramidis hydrochloride | tablet, film coated, oral | 82228-712NDA |
Compare
Other companies listing acoramidis hydrochloride
- Patheon Manufacturing Services LLC19 sites · 319 NDC
Enquiry
Common questions
- Is BridgeBio Pharma, Inc. FDA approved?
- BridgeBio Pharma, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does BridgeBio Pharma, Inc. make?
- 1 product is listed under BridgeBio Pharma, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.